Patent Assignment
Reel/Frame 025764/0684
Corrective Assignment to Correct the Assignee from Biomarin Pharmaceutical Inc. to Lead Therapeutics,Inc. Previously Recorded on Reel 025168 Frame 0650. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2011-01-11
Pages: 9
Assignors
WANG, BING
Executed: 2010-10-11
CHU, DANIEL
Executed: 2010-10-13
LIU, YONGBO
Executed: 2010-10-09
JIANG, QUAN
Executed: 2010-10-09
LU, LEI
Executed: 2010-10-09
Assignee
LEAD THERAPEUTICS, INC.
999 BAYHILL DRIVE, SUITE 130, SAN BRUNO, CALIFORNIA, 94066
Covered Property
(1)
Processes of Synthesizing Dihydropyridophthalazinone Derivatives
Application:
61/302,457 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 20, 2010
From: WANG, BING; CHU, DANIEL; LIU, YONGBO; JIANG, QUAN
To: BIOMARIN PHARMACEUTICAL INC
Reel/Frame 025168/0650 →
Assignment of Assignor's Interest
Feb 1, 2011
From: LEAD THERAPEUTICS, INC.
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 025728/0451 →
Security Interest
Oct 23, 2015
From: MEDIVATION, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036866/0635 →
Assignment of Assignor's Interest
Mar 30, 2016
From: BIOMARIN PHARMACEUTICAL INC.
To: MEDIVATION, INC.
Reel/Frame 038137/0906 →
Assignment of Assignor's Interest
Mar 30, 2016
From: MEDIVATION, INC.
To: MEDIVATION TECHNOLOGIES, INC.
Reel/Frame 038138/0043 →
Release of Security Interest
Sep 28, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MEDIVATION, INC.
Reel/Frame 039873/0219 →